anonymous
Guest
anonymous
Guest
With inflation factored in they will need to raise the WAC price to $10,000.
Marathon Asset Management has entered a definitive agreement to acquire US-based pharmaceutical firm Kaléo in a deal valued at $310m in cash. The purchase value includes potential milestone payments based on revenues of up to nearly $70m in cash for the fiscal years 2022 and 2023.
Kaleo has 2.4 star rating on indeed. It is surprising that they are still in business.
Thursday is going to be bad.
New management coming to clean house
They cut 40 percent but they where low performing territories and low performing reps.
We safe now that they cut the fat
My hobby is selling three key features and benefits and making bank. Never been a low performer.
Don’t be bitter because you are not a chosen one.